Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Key Background The World Health Organization considers substandard and falsified medical products to be one of the urgent health challenges for the next decade. It said such products are manufactured to imitate or replace similar certified products and may contain no active ingredient, the wrong active ingredient or the wrong amount of the correct active ingredient. Fake or poor quality medicines can be dangerous, even deadly, to individuals and cause problems for health systems, the supply chain and societies as a whole, the WHO warned, adding that no country remains untouched from this issue. Falsification can affect anything from generic inexpensive pain medication through to expensive, cutting edge medicine, it warned, with some products found to be toxic and many produced in very poor and unhygienic conditions by unqualified personnel. While some drugs can be made with relative ease in clandestine labs, GLP-1 drugs like semaglutide are relatively complex molecules that can be difficult to make and the injectable nature of the drugs means sterile conditions must be maintained when producing them
It is a professional-use injectable, not a consumer OTC purchase
That's one of the things that's really fascinating to me about this reporting, is we have this booming industry where all of these telehealth companies are selling compounded GLP-1 meds, and they might have to stop next week
Tipton MJ et al
Key Features Research Use Only (RUO) compound 10 mg per bottle Spray format for convenient handling in laboratory settings Manufactured and packaged for research applications Product Specifications Compound Name: Melanotan II (MT2) Form: Spray Total Quantity: 10 mg per bottle Grade: Research Use Only (RUO) Intended Use This product is intended solely for laboratory research and investigational purposes
